1,3,5,7-TETRAMETHYL-6-PHENYL-2,4,8-TRIOXA-6-PHOSPHAADAMANTANE, 95%, 25g

(4S,4'S)-4,4'-Diisopropyl-1,1'-bis(3-isopropylphenyl)-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 98%, 100mg

2-bromo-N-(4-fluorophenyl)acetamide, 95.0%, 5g

Colonne capillaire GC ROTI®Cap-1, 50 m, 0,25 mm, 0,25 µm, 1 pièce(s)

Ethyl 2,5-dimethyloxazole-4-carboxylate, 95.0%, 100mg

(S)-2-Amino-5,5,5-trifluoropentanoic acid hydrochloride, 95%, 1g

4-Chloro-6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazine, 98%, 500mg

Tert-butyl 6-bromo-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate, 98%, 250mg

1-Ethoxycarbonyl-3,4-dihydro-2H-pyridine, 98.0%, 5g

2-methyl-N-(3-pyridinylmethyl)-1-propanamine dihydrochloride, 95.0%, 1g

(R)-Ethyl 4-chloro-3-hydroxybutanoate, 95.0%, 25g

Ethyl 3-fluoro-4-formylbenzoate, 97.0%, 100mg

N-Boc-5-Methoxyindole-2-boronic acid, 95.0%, 25g